197 results on '"Tatenuma, Tomoyuki"'
Search Results
2. Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
3. Association of hospital volume with perioperative and oncological outcomes of robot-assisted laparoscopic radical prostatectomy: a retrospective multicenter cohort study
4. Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group)
5. ASO Visual Abstract: Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy—A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group)
6. Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94)
7. Impact of chronic kidney disease stages on surgical and functional outcomes in robot-assisted partial nephrectomy for localized renal tumors
8. Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group)
9. Objective assessment of laparoscopic targeting skills using a Short-Time Power of Difference (STPOD) method
10. Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
11. MP65-14 THE IMPACT OF GULP1 AS A DOWNSTREAM EFFECTOR OF THE ESTROGEN RECEPTOR-β ON MODULATING CISPLATIN SENSITIVITY IN BLADDER CANCER
12. MP52-04 NOMOGRAM PREDICTING LOCALLY ADVANCED PROSTATE CANCER IN PATIENTS WITH CLINICALLY ORGAN-CONFINED DISEASE WHO UNDERWENT ROBOT-ASSISTED RADICAL PROSTATECTOMY: A RETROSPECTIVE MULTICENTER COHORT STUDY IN JAPAN (THE MSUG94 GROUP)
13. SETD2 regulates SLC family transporter-mediated sodium and glucose reabsorptions in renal tubule
14. Enfortumab vedotin prolongs overall survival in metastatic urothelial carcinoma following pembrolizumab therapy in real‐world data.
15. Impacts of Complete Endophytic Renal Tumors on Surgical, Functional, and Oncological Outcomes of Robot-Assisted Partial Nephrectomy
16. Surgical proficiency in laparoscopic radical cystectomy with extracorporeal urinary diversion and its adequacy for the execution of robot‐assisted radical cystectomy with intracorporeal urinary diversion
17. Early and late urinary continence outcomes after unilateral and bilateral nerve‐sparing robot‐assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group)
18. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
19. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma
20. Early and late urinary continence outcomes after unilateral and bilateral nerve‐sparing robot‐assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group).
21. The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group).
22. Patient‐specific simulations and navigation systems for partial nephrectomy.
23. Predictive factors for pentafecta achievement in robot‐assisted partial nephrectomy for intermediate highly complex RENAL tumors (RENAL score ≥ 7).
24. Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy
25. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma
26. Time-dependent change in relapse sites of renal cell carcinoma after curative surgery
27. Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group)
28. COMPARING LAPAROSCOPIC AND ROBOT-ASSISTED PYELOPLASTY FOR URETERO-PELVIC JUNCTION OBSTRUCTION: INITIAL EXPERIENCE FROM A SINGLE CENTER
29. Additional file 1 of Association of hospital volume with perioperative and oncological outcomes of robot-assisted laparoscopic radical prostatectomy: a retrospective multicenter cohort study
30. Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)
31. A Nomogram for Predicting Prostate Cancer with Lymph Node Involvement in Robot-Assisted Radical Prostatectomy Era: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
32. The Impact of Gleason Grade 3 as a Predictive Factor for Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
33. Prognostic differences among Grade Group 4 subgroups in robotic‐assisted radical prostatectomy
34. A Case of Lymphoepithelioma-Like Carcinoma of the Ureter
35. Short‐term oncological and surgical outcomes of robot‐assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group)
36. Roughness of the renal tumor surface could predict the surgical difficulty of robot‐assisted partial nephrectomy
37. Laparoscopic Nephroureterectomy in Renal Pelvic Urothelial Carcinoma With Situs Inversus Totalis: Preoperative Training Using a Patient-specific Simulator
38. Training on a virtual reality laparoscopic simulator improves performance of live laparoscopic surgery
39. The perioperative outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion compared with laparoscopic radical cystectomy with extracorporeal urinary diversion at a single institution.
40. Early ultrasonographic evaluation of tumor thrombus level during sunitinib therapy for renal cell carcinoma
41. Training on a virtual reality laparoscopic simulator improves performance of live laparoscopic surgery.
42. Correlation of urinary loss rate after catheter removal and long‐term urinary continence after robot‐assisted laparoscopic radical prostatectomy
43. How to reduce the risk of organ injuries during surgical instrument insertion in laparoscopic surgery: Pushing/pressing force analysis using forceps with sensors
44. Clinical use of a patient‐specific simulator for patients who were scheduled for robot‐assisted laparoscopic partial nephrectomy
45. Presurgical downstaging of vena caval tumor thrombus in advanced clear cell renal cell carcinoma using temsirolimus
46. Comparative effectiveness of surgery and radiotherapy for survival of patients with clinically localized prostate cancer: A population‑based coarsened exact matching retrospective cohort study
47. Validation of a kidney model made of N‐composite gel as a training tool for laparoscopic partial nephrectomy
48. Outcome of Palliative Urinary Diversion and Observation for Malignant Extrinsic Ureteral Obstruction
49. Comparative effectiveness of surgery and radiotherapy for survival of clinically localized prostate cancer patients: A population-based coarsened exact matching retrospective cohort study
50. The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.